SALT LAKE CITY, May 10, 2023 /PRNewswire/ — Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced financial results for the first quarter of 2023 ended March 31, 2023. Recent Highlights: Announced…Read More
SERA PROGNOSTICS REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS
